NFKB1 and neuroblastoma: As illustrated in Fig. 6a–f, dox induced IκBα protein degradation whereas ixazomib suppressed dox-induced IκBα protein degradation in all six NB cell lines tested, suggesting that dox-induced NF-κB activity is inhibited by ixazomib.